Introduction:
Most regenerative medicine protocols care mostly about the stem cell: Maternal source, number and route of delivery. Though such elements are significant, they are just part of the entire organic picture.
The treatment concept at Vega Stem Cell Bangkok takes into account the internal environment of the patient prior to the application of regenerative support. It is possible that the level of regenerative signaling can be affected by the inflammatory load of the body, immune activity, blood circulation, metabolic status, mitochondrial dysfunction and cellular energy.
That is why the new “UC-MSCs-DFPP-NAD+” triad concept is attractive. It does not consider stem cell therapy as one isolated event. Instead, it works to prepare the body first by enhancing an environment more conducive to cellular communication and regenerative repair signaling.
Stated simply: we want to not only deliver cells, but to prime the biological environment into which those cells are placed.
Protocol Overview
| Phase | Modality | Primary Target | Supportive Mechanism |
| Phase 1 | DFPP | Circulating inflammatory and lipid burden | Selective blood filtration to reduce selected high-molecular-weight inflammatory molecules, immune complexes, and lipid-related burden |
| Phase 2 | NAD+ Therapy | Cellular energy and mitochondrial function | Supports NAD+ availability for mitochondrial activity, cellular stress response, and repair-related pathways |
| Phase 3 | Stem Cell UC-MSCs | Regenerative signaling and tissue microenvironment | Supports paracrine signaling through extracellular vesicles, growth factors, immune modulation, and tissue repair communication |
Figure 1: Three-Phase Regenerative Preparation Protocol Combining DFPP, NAD+, and UC-MSC Therapy
Phase 1 | DFPP and Blood Environment Preparation
Seeking Rejuvenation / Clearing of the Inflammatory Field Prior to Regenerative Therapies
Double Filtration Plasmapheresis (DFPP) is a modern blood purification technique, selective plasma fractionation method. This is often covered in the advanced supportive care discussion as it is believed to reduce specific circulating inflammatory mediators, lipid-related burden, immune complexes, and other high-molecular-weight factors but can be done so while conserving key components of plasma dependent on the specific clinical protocol.
That distinction is important in regenerative medicine because the ecological health of tissue is influenced by the blood environment it resides within. A high inflammatory load from the body comes at a price in the form of less hospitable tissue microenvironments for repair. Higher inflammatory signaling could influence pathways that are operating in cell-cell communication, immune modulation and regulation of vascular function and tissue resilience.
In selected patients with Stem Cell UC-MSC, DFPP may be used as a preparatory step on or before starting Stem Cell UC-MSC therapy (between five and 10 days prior to intervention) in order to mitigate excess exacerbation of systemic inflammatory stress caused by uremia before introducing cellular signaling support.
Importantly, this does not imply DFPP is mandatory for all patients. Only after medical evaluation, blood test and risk assessment followed by doctor recommendation should it be considered.
Phase 2: NAD+ and Cell Energetics Optimization
Optimizing Mitochondrial Readiness Prior to Stem Cell UC-MSC Treatment
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme that plays an important role in cellular energy production, mitochondrial metabolism, oxidative stress response, and repair-related biological processes.
Energy is needed in every cell for function, communication, repair and biological signaling. If there is less NAD+ available because you are aging, have chronic inflammation, poor sleep better action, metabolic stress worse action each cell gets sick or your toxin overload in each cells too much oxidative burden then cellular resilience goes down.
This is why NAD+ therapy prior to stem cell treatment is being considered as a component of regenerative preparation. The rationale is that you build the cellular energy reserve of the patient before you apply UC-MSCs.
NAD+ may help support:
Mitochondrial energy metabolism
Cellular stress response
DNA repair-related pathways
Metabolic resilience
Recovery capacity
Cellular readiness for signaling
NAD+ does not substitute for UC-MSCs in this model. Alternatively, it might condition the internal milieu to be better primed metabolically for a response to regenerative aid.
Phase 3: Stem Cell UC-MSCs & Regenerative Cellular Signaling
Assisting Repair Communication in a Primed Environment
The Stem Cell UC-MSC stand for umbilical cord-derived mesenchymal stem cells, which have been reported as candidates in regenerative medicine due to this property of releasing biological signals. Such as growth factors, cytokines, extracellular vesicles and other bioactive molecules.
The major mechanism of Stem Cell UC-MSC is not replacement in the organ directly. The better and more responsible answer is paracrine signaling. This suggests that Stem Cell UC-MSC may have the capacity to interact with nearby cells and support immune choreography, modulation of inflammation, features of tissue regeneration signaling and alterations in environmental homeostasis.
When Stem Cell UC-MSC are added to a body with high inflammation, low metabolic health, oxidative stress and low levels of energy at the cellular level, even in potent concentrations the regenerative setting may be less suited. In contrast, if the host is better conditioned through lower levels of inflammation, supportive blood environment, and more optimal cellular energy supplies, Stem Cell UC-MSC signaling may occur in a pro-healing biologic milieu.
This is why combining DFPP, NAD+ and Stem cell UC-MSC therapy together in a structured regenerative support protocol makes perfect sense.
Why the Sequence Matters
As there is a clear sequence in this protocol, so why is that relevant
DFPP supports the blood environment
Using this model, we can think of DFPP as potentially being able to eliminate aetiological and pathological factors that contribute to abnormal inflammation/microangiopathy that would promote cellular distress in diseases. Subsequently, targeted immunotherapies may address the specific active segments of these pathways while DFPP may offer some respite from selective circulating inflammatory and lipid-related burdens which lead to interference with tissue repair/signaling and further pathology development.
NAD+ supports cellular energy
NAD+ might enhance mitochondrial preparedness and cellular resilience, providing a more robust metabolic basis prior to UC-MSC therapy.
Stem Cell UC-MSCs support regenerative medical
These UC-MSCs may therefore secrete paracrine factors that modulate immune response, maintain the balance of inflammation and tissue microenvironment, and support the wound healing process(s) etc.
Collectively, this strategy targets not just the disease-afflicted tissue, but also its host environment the internal biological milieu of the patient receiving regenerative treatment.
Who Should This Combination Regenerative Support Be Considered For?
For patients with chronic inflammatory burden, metabolic imbalance, autoimmune-related stress, degenerative joint disease and neurological support needs — age-related cellular decline, poor recovery or previous suboptimal response to regenerative care — a combined UC-MSCs+DFPP+”free radical”-enhanced NAD+ (dopaminergic pairing) protocol may be considered.
However, the suitability depends on appropriate medical assessment. The assessment should include a focus on inflammatory markers, blood test values, cardiovascular risk factors, kidney and liver function tests, medication use history, a review of the infection risk profile compared with current treatments (eg; T2DM or AS) throughout the course of therapy (when continuing), coagulation profile, metabolic health and evaluation of overall treatment goal.
This is not a protocol that should be called a cure or magic bullet. It is a customized and supportive regenerative strategy.
Conclusion: Getting the body ready for regenerative medicine
Stem Cell UC-MSC: A Tri-Layered Platform in Regenerative Medicine Along with DFPP and NAD+ The model first takes into account the internal state of the body rather than simply stem cell delivery.
DFPP might aid the support of blood microenvironment. NAD+ helps support mitochondrial and cellular energy. This might be followed by paracrine-mediated supportive regenerative signaling, modulating the immune system, balancing inflammation, and acting as stem cell niches through communication between Stem Cell UC-MSC and other cells in the tissue microenvironment.
At Vega Stem Cell Bangkok, this idea is a more holistic perspective on regenerative health: not merely an experience of ¨getting stem cells injected¨ but actually ensuring that the body is primed to receive and respond well to supportive cellular signaling in a medically supervised, personalized manner.
References
Rajman L, Chwalek K, Sinclair DA. Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence. Cell Metab. 2018;27(3):529–547. PMID: 29514063
Verdin E. NAD⁺ in aging, metabolism, and neurodegeneration. Science. 2015;350(6265):1208–1213. PMID: 26785480
Gomes AP, et al. Declining NAD⁺ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell. 2013;155(7):1624–1638. PMID: 24360282
Ding DC, Shyu WC, Lin SZ. Mesenchymal stem cells. Cell Transplant. 2011;20(1):5–14. PMID: 21396235
Pittenger MF, et al. Mesenchymal stem cell perspective: cell biology to clinical progress. NPJ Regen Med. 2019;4:22. PMID: 31646008
Bambauer R, Schiel R, Latza R. Low-density lipoprotein apheresis: an overview. Ther Apher Dial. 2003;7(4):382–390. PMID: 12921680
Nauck M, et al. Effects of plasmapheresis on inflammatory parameters. Eur J Clin Invest. 1996;26(12):1073–1080. PMID: 8985660